ZEPTOSENS
Zeptosens is an ultra-sensitive microarray platform for quantitative proteomic investigations. It provides microarray platforms for sensitive and quantitative protein profiling, and signaling pathway analysis by reverse protein arrays. Its products include ZeptoREADER, a microarray reader for Zeptosens planar wave guide technology; ZeptoMARK protein microarray chips and ZeptoCARRIER for various data points, which are split into arrays. The company also offers proteinarray services, including pro... tein profiling for various samples, such as cell lines, tissues, microdissected cells, and depleted serums; and assay development. In addition, it provides training services, technical and applications support, and technical service and maintenance. The companyโs products are used in various applications, including biomarker/target discovery and validation, cell-based screening, mode of action profiling, selectivity profiling, and toxicology investigation. Its customers include pharma research and development companies, biotech companies, and academic institutions. Zeptosens was founded in 2002 and is headquartered in Wilderswil, Switzerland.
ZEPTOSENS
Industry:
Biotechnology Health Care Medical
Founded:
1998-09-01
Address:
Wilderswil, Bern, Switzerland
Country:
Switzerland
Website Url:
http://www.zeptosens.com
Total Employee:
1001+
Status:
Closed
Contact:
49 214 30 8 00 05
Email Addresses:
[email protected]
Total Funding:
14 M CHF
Technology used in webpage:
Matomo CSC Global DNS
Similar Organizations
Bio-Santis
Bio-Santis is a multi-site medical biology laboratory which offers diagnostic services for diabetes and other medical conditions.
PEPperPRINT
PEPperPRINT offers a fully customizable peptide microarray platform for comprehensive proteome interaction studies.
SATT Ouest Valorisation
Ouest Valorisation provides research and technology solutions.
Investors List
Techno Venture Management
Techno Venture Management investment in Series B - Zeptosens
Swiss Life Private Equity Partners
Swiss Life Private Equity Partners investment in Series B - Zeptosens
Techno Venture Management
Techno Venture Management investment in Venture Round - Zeptosens
Official Site Inspections
http://www.zeptosens.com
- Host name: bayertech2.sys.dom.de
- IP address: 83.137.171.227
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Zeptosens"
Zeptosens - Products, Competitors, Financials, Employees, โฆ
When was Zeptosens founded? Zeptosens was founded in 1998. Where is Zeptosens's headquarters? Zeptosens's headquarters is located at Benkenstrasse 254, Witterswil. What is โฆSee details»
Bayer Switzerland - Overview, News & Similar companies - ZoomInfo
Jul 18, 2022 Zeptosens AG is a company that operates in the Pharmaceuticals industry. It employs 101-250 people and has $5M-$10M of revenue. The company is head quartered in โฆSee details»
Zeptosens - coverager.com
Zeptosens Zeptosens is an ultra-sensitive microarray platform for quantitative proteomic investigations. Comparison tool. Overview; Funding; Headquarters Wilderswil, Bern, โฆSee details»
Zeptosens AG | www.inknowvation.com
Jun 25, 2013 Since 2005, Zeptosens AG has operated as a subsidiary of Bayer Technology Services GmbH.Zeptosens AG provides microarray platforms for sensitive and quantitative โฆSee details»
Zeptosens | Company | Mindmaps
Zeptosens is a company that provides ultra-sensitive microarray platforms for quantitative proteomic investigations. Their products include ZeptoREADER, ZeptoMARK protein โฆSee details»
Zeptosens - Company Profile - Tracxn
Dec 30, 2023 Zeptosens - Microarrays for quantitative proteomic analysis. Raised a total funding of $8.3M over 2 rounds from 3 investors. Zeptosens has 115 competitors.See details»
Zeptosens AG - Drug pipelines, Patents, Clinical trials - Synapse
Explore Zeptosens AG with its drug pipeline, therapeutic area, technology platform, .See details»
Zeptosens - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 27, 2001: Series B - โฆSee details»
Bayer Technology Services GmbH acquires Zeptosens AG
Mar 10, 2005 Zeptosens AG was established 1998 as a spin-off from Novartis. The company's core business is the development, production and sale of a highly sensitive chip system based โฆSee details»
US-Swiss team announce leap in microarrays for genetics
Dec 17, 2003 The progress of the Basel-based Zeptosens, a maker of new measurements systems for DNA and RNA research was based on the results of a study it carried out with ViaLogy Corp in the US.See details»
Zeptosens - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Zeptosens . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. About. Zeptosens is โฆSee details»
Zeptosens - IT History Society
Zeptosens is an ultra-sensitive microarray platform for quantitative proteomic investigations.Zeptosens is an ultra-sensitive microarray platform for quantitative proteomic โฆSee details»
High Precision RPPA: Concept, Features, and Application
Dec 10, 2019 We explicitly would like to acknowledge the many contributions of staff and associates of Zeptosens AG, especially the former Zeptosens protein array development team โฆSee details»
Swiss Zeptosens Tests the Limits of Detection With Its
Aug 2, 2002 With ultra-sensitive detection down to zeptomoles โ just hundreds to thousands of molecules โ Zeptosens is confident it can conquer the market for second-wave DNA chips โฆSee details»
Zeptosens' protein microarrays: A novel high performance โฆ
A ZeptoMARK TM reverse phase protein microarray (RPPM) platform (Zeptosens AG, Witteswil, ... This revelation led scientists to hypothesize about a higher order of organization within the โฆSee details»
Zeptosens' protein microarrays: A novel high performance โฆ
Zeptosens has developed a revolutionary new bioanalytical system based on the proprietary planar waveguide technology which allows us to perform multiplexed, quantitative โฆSee details»
Zeptosens' protein microarrays: a novel high performance โฆ
Zeptosens has developed a revolutionary new bioanalytical system based on the proprietary planar waveguide technology which allows us to perform multiplexed, quantitative โฆSee details»
High Precision RPPA: Concept, Features, and Application ... - PubMed
Ideally the full workflow from sample preparation to data visualization shall be covered.This book chapter describes the key elements of the integrated Zeptosens RPPA platform. It addresses โฆSee details»
A single lysis solution for the analysis of tissue samples by โฆ
Oct 2, 2008 Here, we report a comparative study of a lysis buffer โ cell lysis buffer 1 (CLB1) โ commercialized by Zeptosens [a division of Bayer (Schweiz) AG] that can be used for gel and โฆSee details»